Open AccessThe efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
Author(s) -
Ying Guan,
Anchuan Li,
Weiwei Xiao,
Shuai Liu,
Binbin Chen,
TaiXiang Lu,
Chong Zhao,
Fei Han
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.5271
Subject(s) - medicine , nasopharyngeal carcinoma , chemoradiotherapy , radiation therapy , oncology , incidence (geometry) , chemotherapy , gastroenterology , surgery , physics , optics
To evaluate the short-term efficacy and safety of recombinant human endostatin (Endostar) combined with chemoradiotherapy for the treatment of advanced, locally recurrent nasopharyngeal carcinoma (NPC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom